| Citation: |
YU Ling, JIA Yingna, WANG Yi. Clinical significance of coagulation related indexes in patients with intrahepatic cholestasis of pregnancy[J]. Journal of Clinical Medicine in Practice, 2022, 26(20): 119-123, 135. DOI: 10.7619/jcmp.20221818
|
To investigate the clinical significance of four coagulation parameters, the D-dimer and antiphospholipid antibody detection in pregnant women with intrahepatic cholestasis of pregnancy (ICP).
Eighty pregnant women with ICP were selected as case group, and another 80 healthy pregnant women were selected as control group. The case group was divided into mild ICP group (n=51) and severe ICP group (n=29) according to the severity of the disease. Plasma prothrombin time (PT), activated partial thrombin time (APTT), thrombin time (TT), fibrinogen (FIB), D-dimer, serum anticardiolipin antibody (ACA), antibody against β2 glycoprotein Ⅰ (anti-β2GP Ⅰ) and normalized ratio of lupus anticoagulant (LA) were compared among different groups. Values of FIB, D-dimer, ACA, anti-β2GP Ⅰ and normalized ratio of LA in predicating adverse pregnancy outcomes were evaluated by receiver operating characteristic (ROC) curve.
Before delivery, the plasma FIB and D-dimer levels in the mild ICP group and the severe ICP group were significantly higher than those in the control group, and these indexes in the severe ICP group were also significantly higher than those in the mild ICP group (P < 0.05). Before delivery, the serum ACA, anti-β2GP Ⅰ and normalized ratio of LA in the mild ICP group and the severe ICP group were significantly higher than those in the control group, and these indexes in the severe ICP group were also significantly higher than those in the mild ICP group (P < 0.05). The cesarean section rate and the incidence rate of fetal intrauterine growth restriction in the case group were significantly higher than those in the control group (P < 0.05); among the 80 pregnant women with ICP, 32 cases had adverse pregnancy outcomes, and the levels of plasma FIB, D-dimer, serum ACA, anti-β2GP Ⅰ and normalized ratio of LA in the bad pregnancy group were significantly higher than those in the good pregnancy group (P < 0.05). When plasma FIB was greater than 4.520 g/L, the area under the curve (AUC) for predicting adverse pregnancy outcomes in the ICP pregnant women was 0.757, with a sensitivity of 71.9% and a specificity of 84.4%; when plasma D-dimer was greater than 1.860 mg/L, the AUC was 0.828, with a sensitivity of 78.1% and a specificity of 81.3%; when serum ACA was greater than 7.915 mU/mL, the AUC was 0.774, with a sensitivity of 81.3% and a specificity of 75.0%; when serum anti-β2GP Ⅰ was greater than 6.085 mU/mL, the AUC was 0.875, with a sensitivity of 87.5% and a specificity of 68.8%; when normalized ratio of LA was greater than 1.305, the AUC was 0.809, with a sensitivity of 84.4% and a specificity of 71.3%.
There are abnormal conditions of coagulation, fibrinolysis and immunity in pregnant women with ICP during delivery, and the degree of abnormality is related to the severity of ICP. The detection of FIB, D-dimer and antiphospholipid antibody has positive significance for predicting the pregnancy outcomes of the pregnant women with ICP.
| [1] |
MORTON A, LAURIE J. The biochemical diagnosis of intrahepatic cholestasis of pregnancy[J]. Obstet Med, 2019, 12(2): 76-78. doi: 10.1177/1753495X18795979
|
| [2] |
吴玮, 余菁雯, 蒋晖. 孕妇发生妊娠期肝内胆汁淤积症的风险列线图模型的建立研究[J]. 实用临床医药杂志, 2022, 26(4): 18-23. doi: 10.7619/jcmp.20213161
|
| [3] |
PALMER K R, LIU X H, MOL B W. Management of intrahepatic cholestasis in pregnancy[J]. Lancet, 2019, 393(10174): 853-854. doi: 10.1016/S0140-6736(18)32323-7
|
| [4] |
邱智枫, 张杰良, 黄雪珍. 临产妊娠期肝内胆汁淤积症患者凝血功能分析[J]. 国际检验医学杂志, 2020, 41(1): 117-119. doi: 10.3969/j.issn.1673-4130.2020.01.028
|
| [5] |
史艳春. 孕妇妊娠不同时期凝血功能四项、D-二聚体、FDP指标检测的临床意义[J]. 川北医学院学报, 2018, 33(1): 114-117. https://www.cnki.com.cn/Article/CJFDTOTAL-NOTH201801034.htm
|
| [6] |
袁峰, 袁晓华, 胡盈, 等. 不同亚型抗磷脂抗体表达D-二聚体与妊娠期高血压患者不良妊娠结局的关系[J]. 中国临床医生杂志, 2019, 47(10): 1229-1232. doi: 10.3969/j.issn.2095-8552.2019.10.032
|
| [7] |
贺晶, 杨慧霞, 段涛, 等. 妊娠期肝内胆汁淤积症诊疗指南(2015)[J]. 临床肝胆病杂志, 2015, 31(10): 1575-1578. doi: 10.3969/j.issn.1001-5256.2015.10.003
|
| [8] |
田小飞, 马欢. 妊娠肝内胆汁淤积症产妇血清总胆汁酸、甘胆酸水平检测及新生儿肺损伤状况分析[J]. 实用临床医药杂志, 2019, 23(22): 85-87. doi: 10.7619/jcmp.201922029
|
| [9] |
DIXON P H, WILLIAMSON C. The pathophysiology of intrahepatic cholestasis of pregnancy[J]. Clin Res Hepatol Gastroenterol, 2016, 40(2): 141-153. doi: 10.1016/j.clinre.2015.12.008
|
| [10] |
GROTTKE O, MALLAIAH S, KARKOUTI K, et al. Fibrinogen supplementation and its indications[J]. Semin Thromb Hemost, 2020, 46(1): 38-49. doi: 10.1055/s-0039-1696946
|
| [11] |
GUTIÉRREZ GARCÍA I, PÉREZ CAÑADAS P, MARTÍNEZ URIARTE J, et al. D-dimer during pregnancy: establishing trimester-specific reference intervals[J]. Scand J Clin Lab Invest, 2018, 78(6): 439-442. doi: 10.1080/00365513.2018.1488177
|
| [12] |
王淑丽. 妊娠期肝内胆汁淤积症孕妇血液流变学、凝血功能改变对妊娠结局的影响[J]. 医学理论与实践, 2018, 31(18): 2787-2789. https://www.cnki.com.cn/Article/CJFDTOTAL-YXLL201818051.htm
|
| [13] |
朱婷, 吕艳关. 妊娠期肝内胆汁淤积症患者血清肝胆酸、总胆汁酸水平及血浆凝血功能检测的临床诊断意义[J]. 现代检验医学杂志, 2019, 34(4): 79-82. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYN201904019.htm
|
| [14] |
孙晓彤, 郭囡, 曲涛, 等. 凝血功能与炎症标志物在妊娠期肝内胆汁淤积症中的变化分析[J]. 中华生殖与避孕杂志, 2020, 40(8): 638-643.
|
| [15] |
何妍春, 胡文胜, 曹芬. 血清免疫学指标与妊娠期肝内胆汁淤积症母婴结局关系的调查分析[J]. 中国卫生检验杂志, 2020, 30(10): 1239-1241. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWJZ202010026.htm
|
| [16] |
孔艳, 孔祥. 妊娠期肝内胆汁淤积症免疫因素的研究进展[J]. 中华妇幼临床医学杂志: 电子版, 2015, 11(6): 798-800. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHFY201506035.htm
|
| [17] |
WANG D, LV W X, ZHANG S C, et al. Advances in the research on anticardiolipin antibody[J]. J Immunol Res, 2019, 2019: 8380214.
|
| [18] |
SINGH A, NANGIA A, SHARMA S, et al. A study of anti beta-2 glycoprotein I and anti-prothrombin antibodies in patients with unexplained recurrent pregnancy losses[J]. Indian J Hematol Blood Transfus, 2016, 32(2): 198-201.
|
| [19] |
GHOSH J B. Lupus anticoagulant-hypoprothrombinemia syndrome: correspondence[J]. Indian J Pediatr, 2019, 86(5): 483-484.
|
| [20] |
李骏, 徐莺, 胡峥. 抗心磷脂抗体与妊娠期高血压疾病严重程度和母婴结局的相关性[J]. 医学临床研究, 2020, 37(7): 1011-1013.
|
| [21] |
张晨露, 蒋敏, 罗健英. 抗磷脂抗体和子痫前期的研究进展[J]. 中华临床医师杂志: 电子版, 2020, 14(2): 140-143. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYD202002013.htm
|
| [22] |
孙笑丛, 马红玲, 赵娟. 凝血功能指标及抗磷脂抗体检测在妊娠合并抗磷脂综合征患者诊断中的价值[J]. 中国妇幼保健, 2019, 34(21): 4877-4880. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201921014.htm
|
| [23] |
杨永红, 孙阳, 李小兰, 等. 妊娠期肝内胆汁淤积症孕产妇血清胆汁酸水平与肝功能和妊娠结局的相关性[J]. 肝脏, 2020, 25(5): 544-547. https://www.cnki.com.cn/Article/CJFDTOTAL-ZUAN202005040.htm
|
| [24] |
张洁. 妊娠期肝内胆汁淤积症血小板PAC-1、CD62P表达的研究[D]. 杭州: 杭州师范大学, 2018.
|
| [25] |
陈雅娟, 陈亮. ICP患者纤维蛋白原、D-二聚体、血小板、IL-18、TNF-α和血液流变学指标变化及其对妊娠结局的影响[J]. 中国妇幼健康研究, 2018, 29(4): 441-444. https://www.cnki.com.cn/Article/CJFDTOTAL-SANE201804013.htm
|
| [26] |
刘丽园, 陈晓燕, 唐玲. 子痫前期患者抗磷脂抗体水平与妊娠结局的关系研究[J]. 中国妇幼健康研究, 2019, 30(7): 807-810. https://www.cnki.com.cn/Article/CJFDTOTAL-SANE201907008.htm
|
| 1. |
冯晓霞，陈玉仙，张晓萍. 妊娠期肝内胆汁淤积症合并乙型肝炎病毒感染与患者妊娠结局相关性研究. 陕西医学杂志. 2025(02): 227-230 .
| |
| 2. |
刘佳，于雅彬，王兰，李英，于欣，蔡永艳，马娜，阎志新. 重症腺病毒肺炎患儿凝血功能和免疫功能特征及其临床意义. 实用临床医药杂志. 2025(05): 122-126 .
本站查看
| |
| 3. |
王晶晶，李萍，高尚啸，周玥. 阶梯护理决策辅助干预在妊娠期肝内胆汁淤积症患者中的应用. 国际护理学杂志. 2024(09): 1625-1629 .
| |
| 4. |
宋对对，牛丽娜，张小娟，马萍，卫晓娟. 妊娠期肝内胆汁淤积症患者不良妊娠结局影响因素. 中国计划生育学杂志. 2024(07): 1586-1590 .
| |
| 5. |
潘伟杰，程福安，李婉莹，林炳柱. NLR和凝血四项与妊娠期肝内胆汁淤积症病情程度的相关性及检测价值. 实用检验医师杂志. 2024(03): 222-224 .
| |
| 6. |
陈慧. 妊娠期肝内胆汁淤积症孕妇血清总胆酸水平和胎儿心脏功能的相关性. 临床研究. 2023(09): 44-46 .
| |
| 7. |
罗钊琰，唐征宇. 茵陈蒿汤加味辅助治疗湿热郁结型妊娠肝内胆汁淤积症的临床效果. 中国社区医师. 2023(36): 64-66 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: